Results 121 to 130 of about 114,714 (200)

Transcription associated cyclin-dependent kinases as therapeutic targets for prostate cancer. [PDF]

Oncogene, 2022
Constantin TA, Greenland KK, Varela-Carver A, Bevan CL.   +3 more
europepmc   +1 more source

When cyclin-dependent kinases meet viral infections, including SARS-CoV-2. [PDF]

J Med Virol, 2022
Yan Y, Tang YD, Zheng C.
europepmc   +1 more source

Mechanistic Roles of Transcriptional Cyclin-Dependent Kinases in Oncogenesis: Implications for Cancer Therapy. [PDF]

Cancers (Basel)
Alrouji M, Alshammari MS, Anwar S, Venkatesan K, Shamsi A.   +4 more
europepmc   +1 more source

Comprehensive Analysis of Role of Cyclin-Dependent Kinases Family Members in Colorectal Cancer. [PDF]

Front Oncol, 2022
Guan L, Tang Y, Li G, Qin Z, Li S.
europepmc   +1 more source

Regulatory mimicry of cyclin-dependent kinases by a conserved herpesvirus protein kinase. [PDF]

Proc Natl Acad Sci U S A
Koyanagi N, Hengphasatporn K, Kato A, Nobe M, Takeshima K, Maruzuru Y, Maenaka K, Shigeta Y, Kawaguchi Y.   +8 more
europepmc   +1 more source

Design, Synthesis, Antitumour Evaluation, and In Silico Studies of Pyrazolo-[1,5-<i>c</i>]quinazolinone Derivatives Targeting Potential Cyclin-Dependent Kinases. [PDF]

Molecules, 2023
Zheng D, Yang C, Li X, Liu D, Wang Y, Wang X, Zhang X, Tan Y, Zhang Y, Li Y, Xu J.   +10 more
europepmc   +1 more source

Differential activity of specific inhibitors of transcription regulating cyclin-dependent kinases in thyroid cancer cells. [PDF]

Endocr Relat Cancer
Rajan N, Khanal T, Adik A, Valenciaga A, Nigam A, Liyanarachchi S, Ringel MD.   +6 more
europepmc   +1 more source

Risk of Cardiovascular Events with Cyclin-Dependent Kinases 4 and 6 (CDK 4/6) Inhibitors among Patients with Advanced Breast Cancer: A Systematic Review and Network Meta-Analysis. [PDF]

Rev Cardiovasc Med, 2023
Liu YS, Dong K, Park C.
europepmc   +1 more source

Efficacy of cyclin-dependent kinases 4 and 6 inhibitors in the treatment of HR +/HER2 - advanced breast cancer: a meta-analysis. [PDF]

Eur J Med Res
Danbala IA, Wang X, Su Y, Tang H, Sheng W, Shaibu Z, Isah I, Yuan X.   +7 more
europepmc   +1 more source

Biomarkers of primary and secondary resistance to cyclin dependent kinases 4 and 6 inhibitors in metastatic estrogen receptor-positive/human epidermal growth factor receptor 2-negative breast cancer: a narrative review. [PDF]

Transl Breast Cancer Res
Stravodimou A, Voutsadakis IA.
europepmc   +1 more source